Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Cleaning and Sanitization of Bioreactors – V 2.0

Posted on By


Biosimilars: SOP for Cleaning and Sanitization of Bioreactors – V 2.0


Standard Operating Procedure for Cleaning and Sanitization of Bioreactors in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/098/2025
Supersedes SOP/BS/098/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the validated cleaning and sanitization procedures for bioreactors used in biosimilar manufacturing, ensuring removal of residues and microbial control in accordance with cGMP standards.

2. Scope

This SOP applies to stainless-steel bioreactors and single-use bioreactor systems (SUBs) used in upstream processes of biosimilar production.

3. Responsibilities

  • Manufacturing: Execute cleaning/sanitization as per validated protocols and document activities.
  • Engineering: Maintain CIP/SIP systems, validate cleaning cycles, and troubleshoot equipment.
  • QA: Approve cleaning validation reports and review cleaning logs.

4. Accountability

The Manufacturing Manager is accountable for ensuring bioreactors are cleaned and sanitized according to this SOP before and after each production batch.

5. Procedure

5.1 Cleaning of Stainless-Steel Bioreactors

  1. Ensure the bioreactor is empty and all harvest lines are drained.
  2. Initiate CIP cycle using the control panel:
    • Pre-rinse with WFI or RO water for 10 minutes.
    • Alkaline wash (e.g., 1% NaOH at 60°C for 20 minutes).
    • Intermediate rinse with WFI until conductivity <1 µS/cm.
    • Acid wash (e.g., 0.5% nitric acid) if required.
    • Final rinse with WFI.
  3. Inspect internal surfaces using a borescope if accessible.

5.2 Sanitization (SIP) of Stainless-Steel Bioreactors

  1. Perform SIP using clean steam (121°C) through all ports for minimum 30 minutes hold time.
  2. Validate temperature probes reach ≥121°C during cycle.
  3. Maintain log of time, temperature, and pressure (Annexure-2).

5.3 Cleaning and Sanitization of Single-Use Bioreactors

  1. Use pre-sterilized bags with gamma irradiation certification.
  2. If pre-use rinse required:
    • Rinse with sterile WFI for 5–10 minutes at ambient temperature.
  3. Post-run, discard bag and sanitize shell with 70% IPA.

5.4 Cleaning Verification

  1. Swab rinsing ports and interior for residual protein or cleaning agent.
  2. Conduct TOC or conductivity test on rinse water; limits:
    • TOC < 500 ppb
    • Conductivity < 1.3 µS/cm

5.5 Documentation

  1. Record all activities in Bioreactor Cleaning Log (Annexure-1).
  2. Attach SIP printouts and cleaning validation results.

6. Abbreviations

  • CIP: Clean-In-Place
  • SIP: Sterilize-In-Place
  • TOC: Total Organic Carbon
  • QA: Quality Assurance

7. Documents

  1. Bioreactor Cleaning Log – Annexure-1
  2. SIP Cycle Monitoring Sheet – Annexure-2

8. References

  • ICH Q9 – Quality Risk Management
  • WHO TRS 1010 Annex 4 – GMP for Biological Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Bioreactor Cleaning Log

Date Bioreactor ID CIP Cycle Type Operator TOC Result Remarks
04/05/2025 BR-SS-500L Standard Ajay Verma 410 ppb Pass

Annexure-2: SIP Cycle Monitoring Sheet

Date Cycle Start Hold Start Hold End Min Temp (°C) Operator
04/05/2025 09:00 09:10 09:40 122.3 Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included single-use bioreactor sanitization and TOC limits Periodic GMP review
See also  Biosimilars: SOP for Periodic Equipment Cleaning Schedule - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Control of Alcohol Evaporation Loss – V 2.0
Next Post: Creams: SOP for Inline Cleaning of Mixing Blades – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version